FIELD REFERENCE
Full criteria & treatment guidance
Indications
- SO-F-02 lists this product/category for eligible firefighting personnel in the authorized FS-ARN role. Use is limited to the indications printed on the actual container; the policy does not identify one active-ingredient formulation.
Contraindications & local exclusions
- SO-F-02 excludes known allergy to the specific medication. A complete formulation-specific contraindication list is not established for this category; identify the active ingredients and read the current product label before use.
Precautions
- The category name does not establish dose, route, age eligibility or interactions. Follow the container label and FS-ARN program restrictions. No general pediatric or 9-1-1 authority is established by this listing.
- These are selected safety checks, not a complete prescribing monograph. Product labeling and OCEMS authorization answer different questions; confirm the actual product, patient population and applicable order.
Scope & authority
- FS-ARN scope only; this listing is not a general ALS/BLS administration order.
- SO-F-02 supplies no pediatric field regimen.
Adult / adolescent
- SO-F-02 permits an authorized Fire Service RN to maintain this listed OTC product/category while functioning in the fire-service role. It is made available to firefighting personnel without a known allergy to the product.
- Use this medication only for the indications and doses printed on its container. OCEMS does not publish a universal dose for this product. Eligible personnel must obtain the medication from its container without assistance.
Pediatric
- SO-F-02 applies to adult and adolescent fire-service personnel. It does not authorize pediatric 9-1-1 dosing, and this page does not add consumer pediatric doses.
- Do not convert a package’s consumer pediatric directions into OCEMS field authority. Use an applicable pediatric standing order or medical direction for a child requiring care.
Pediatric dosing availability
- SO-F-02 supplies no pediatric 9-1-1 dosing or administration authority. This page does not add consumer pediatric doses.
| Weight | OCEMS pediatric dose |
|---|---|
| Any weight | No general OCEMS pediatric dose is listed; follow the applicable order or medical direction. |
Use, monitoring & documentation
- Identify the exact product, active ingredients, strength, and label before use; products in a named OTC category can have different formulations.
- Follow the product’s labeled indications, exclusions, dose, and interval within the authorized program. The absence of an EMS numerical dose here is intentional: SO-F-02 delegates those details to the product label.
UNDERSTAND THE CARE
“Or equivalent” still requires a product check
Identify the actual preparation and active ingredients rather than treating a familiar brand name as a complete specification. Products described as equivalent may have different labels. The guide cannot provide a universal exclusion list until the selected formulation is known. The linked OCEMS document establishes the program context; a product-specific label answers a different question about the selected preparation.
Applying the guidance
For a substitute labeled “equivalent,” compare the actual preparation rather than carrying over the familiar brand name into the record. Identify its ingredients and intended use, and retain the selected label with the program supply. The OCEMS category name alone does not settle equivalence or establish the directions for a replacement container. Record what was actually available and used. SO-F-02.
Diagram text & teaching checkpoints
- Program
- Eligible FS-ARN setting and personnel.
- Identity
- Exact product, ingredients and formulation.
- Label
- Current directions, allergy and exclusions.
- Record
- Product and actual amount; no invented pediatric regimen.
Sources for this explanation
Original OCMedic teaching synthesis of the references below. Educational expansion updated ; this is not a new independent clinical-review date. Source-specific dates and limitations remain in the full guidance.